Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Clinical significance of CD8 and FoxP3 tumor-infiltrating lymphocytes and MFG-E8 expression in lower rectal cancer with preoperative chemoradiotherapy.

Authors:
Yuzo Harada Shinsuke Kazama Teppei Morikawa Hirofumi Sonoda Hiroaki Ishi Shigenobu Emoto Koji Murono Manabu Kaneko Kazuhito Sasaki Yasutaka Shuno Takeshi Nishikawa Toshiaki Tanaka Kazushige Kawai Keisuke Hata Hiroaki Nozawa Tetsuo Ushiku Hideaki Tahara Soichiro Ishihara

Mol Clin Oncol 2021 May 5;14(5):87. Epub 2021 Mar 5.

Division of Surgical Oncology, Department of Surgery, Faculty of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.

Preoperative chemoradiotherapy (CRT) for rectal cancer contributes to tumor down-staging and decreases locoregional recurrence. However, each patient shows a significantly different response to CRT. Therefore, the identification of predictive factors to CRT response would be beneficial to avoid unnecessary treatment. Cancer immunity in patients has been suggested to play an important role in the eradication of the tumor by CRT. In the present study, the utility of CD8 and forkhead box P3 (FoxP3) tumor-infiltrating lymphocytes (TILs) and the expression of a novel immuno-regulatory factor, lactadherin (MFG-E8), in predicting CRT effectiveness in patients with rectal cancer was examined. A total of 61 patients with rectal cancer, who underwent curative resection following CRT were included in the study. The numbers of CD8 and FoxP3 TILs in a biopsy taken before CRT and MFG-E8 expression level in the specimens obtained at the time of the surgery after CRT were examined using immunohistochemical staining, and their association with clinicopathological characteristics, including patient survival, was determined. The tumors with more CD8 TILs in the biopsy samples before CRT showed a significantly more favorable CRT response. The patients with tumors and a higher number of CD8 TILs before CRT also exhibited significantly longer disease-free and overall survival times. Higher MFG-E8 expression level in post-CRT specimens was significantly associated with favorable CRT response; however, no significant association was found with any other clinicopathological characteristics, including survival time. The number of CD8 TILs before CRT was a valuable predictor for CRT response and was associated with favorable prognosis in patients with lower rectal cancer and who were treated with CRT. High MFG-E8 expression level after CRT was also associated with a favorable CRT response.

Download full-text PDF

 Source
http://dx.doi.org/10.3892/mco.2021.2249DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976375PMC
May 2021

Publication Analysis

Top Keywords

rectal cancer
20
crt response
20
crt
17
mfg-e8 expression
16
expression level
12
cd8 tils
12
associated favorable
12
favorable crt
12
lower rectal
8
number cd8
8
association clinicopathological
8
clinicopathological characteristics
8
preoperative chemoradiotherapy
8
tils crt
8
tumor-infiltrating lymphocytes
8
patients rectal
8
foxp3 tumor-infiltrating
8
characteristics including
8
cd8 foxp3
8
tils biopsy
8

Keyword Occurance

Similar Publications

Who is a candidate for nonoperative management of early-stage rectal cancer?

Authors:
Christopher L Hallemeier

Clin Adv Hematol Oncol 2022 May;20(5):281-283

Mayo Clinic, Rochester, Minnesota.

View Article and Full-Text PDF
May 2022
Similar Publications

Folate intake and risk of colorectal cancer: a systematic review and up-to-date meta-analysis of prospective studies.

Authors:
Hongjuan Fu Jianbo He Cancan Li Zhihui Deng Hui Chang

Eur J Cancer Prev 2022 May 11. Epub 2022 May 11.

College of Food Science, Southwest University, Chongqing, China.

Purpose: Colorectal cancer is one of the most commonly diagnosed and deadly cancers worldwide. Epidemiological studies on the relationship between folate intake and the risk of colorectal cancer have reported inconsistent findings since folate fortification in the USA. For this situation, we conducted a large number of data analyses to study the relationship between folate intake and colorectal cancer risk. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

[A Case of Fournier's Gangrene during Second-Line IRIS plus Bevacizumab Chemotherapy for Rectal and Anal Canal Cancer].

Authors:
Shunsuke Imamura Nozomu Ogura Yu Aoki Mai Hoshino Gen Sakai Fumiki Toriumi Takashi Endo Mika Watanabe Atsushi Nakazawa Shigemichi Hirose Shinsuke Funakoshi

Gan To Kagaku Ryoho 2022 May;49(5):597-599

Dept. of Medical Oncology, Tokyo Saiseikai Central Hospital.

A 52-year-old man diagnosed with Stage ⅢA rectal and anal canal cancer underwent abdominal perineal resection using Miles's method. Two years later, local recurrence and lung metastases were detected using contrasted CT imaging. First-line chemotherapy of XELOX was administered for 4 months until the disease progressed and lung metastases developed. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

A new technique for robotic lateral pelvic lymph node dissection for advanced low rectal cancer with emphasis on en bloc resection and inferior vesical vessel preservation.

Authors:
Tetsuo Ishizaki Junichi Mazaki Masanobu Enomoto Ryutaro Udo Tomoya Tago Kenta Kasahara Hiroshi Kuwabara Kenji Katsumata Yuichi Nagakawa

Surg Endosc 2022 May 16. Epub 2022 May 16.

Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, 6-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.

Background: Lateral pelvic lymph node (LPLN) dissection is becoming increasingly important in the treatment of advanced low rectal cancer patients. However, the surgery has several disadvantages, including its technical complexity and high risk of urinary dysfunction. Herein, we report a new technique for robotic lateral pelvic lymph node dissection for advanced low rectal cancer with emphasis on en bloc resection and inferior vesical vessel preservation. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Hereditary Colorectal Cancer.

Authors:
Heather Hampel Matthew F Kalady Rachel Pearlman Peter P Stanich

Hematol Oncol Clin North Am 2022 May 13. Epub 2022 May 13.

Division of Gastroenterology, Hepatology & Nutrition, The Ohio State University Wexner Medical Center, 395 W 12th Avenue, Second Floor, Columbus, OH 43210, USA. Electronic address: https://twitter.com/docstanich.

Around 10% to 16% of colorectal cancer patients have a pathogenic variant in a cancer susceptibility gene. Some of these variants are in cancer genes that are associated with colorectal cancer while others are not. The hereditary colorectal cancer syndromes can be divided into two major categories, the nonpolyposis and the polyposis conditions. Read More

View Article and Full-Text PDF
May 2022
Similar Publications
}